1. Home
  2. EYPT vs DDD Comparison

EYPT vs DDD Comparison

Compare EYPT & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • DDD
  • Stock Information
  • Founded
  • EYPT 1987
  • DDD 1986
  • Country
  • EYPT United States
  • DDD United States
  • Employees
  • EYPT N/A
  • DDD N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • DDD Computer peripheral equipment
  • Sector
  • EYPT Industrials
  • DDD Technology
  • Exchange
  • EYPT Nasdaq
  • DDD Nasdaq
  • Market Cap
  • EYPT 439.4M
  • DDD 386.0M
  • IPO Year
  • EYPT 2005
  • DDD N/A
  • Fundamental
  • Price
  • EYPT $9.17
  • DDD $2.97
  • Analyst Decision
  • EYPT Strong Buy
  • DDD Buy
  • Analyst Count
  • EYPT 8
  • DDD 3
  • Target Price
  • EYPT $27.29
  • DDD $3.00
  • AVG Volume (30 Days)
  • EYPT 1.1M
  • DDD 2.4M
  • Earning Date
  • EYPT 11-07-2024
  • DDD 11-26-2024
  • Dividend Yield
  • EYPT N/A
  • DDD N/A
  • EPS Growth
  • EYPT N/A
  • DDD N/A
  • EPS
  • EYPT N/A
  • DDD N/A
  • Revenue
  • EYPT $45,713,000.00
  • DDD $454,796,000.00
  • Revenue This Year
  • EYPT N/A
  • DDD N/A
  • Revenue Next Year
  • EYPT N/A
  • DDD $5.45
  • P/E Ratio
  • EYPT N/A
  • DDD N/A
  • Revenue Growth
  • EYPT 7.50
  • DDD N/A
  • 52 Week Low
  • EYPT $5.86
  • DDD $1.72
  • 52 Week High
  • EYPT $30.99
  • DDD $6.85
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 38.25
  • DDD 45.82
  • Support Level
  • EYPT $11.26
  • DDD $2.58
  • Resistance Level
  • EYPT $12.23
  • DDD $3.80
  • Average True Range (ATR)
  • EYPT 0.97
  • DDD 0.26
  • MACD
  • EYPT -0.30
  • DDD -0.05
  • Stochastic Oscillator
  • EYPT 3.24
  • DDD 31.56

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About DDD 3D Systems Corporation

3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.

Share on Social Networks: